KEGG   DRUG: Adsorbed hepatitis B vaccine
Entry
D06475                      Drug                                   
Name
Adsorbed hepatitis B vaccine (JP18);
Bimmugen (TN)
Product
ENGERIX-B (A-S Medication Solutions), ENGERIX-B (GlaxoSmithKline Biologicals SA), HEPLISAV-B (A-S Medication Solutions), HEPLISAV-B (Bamboo US BidCo LLC), HEPLISAV-B (Dynavax Technologies Corporation), PREHEVBRIO (VBI Vaccines (Delaware)), RECOMBIVAX HB (Merck Sharp & Dohme LLC)
Remark
Therapeutic category: 6313
ATC code: J07BC01
Product: D06475<JP/US>
Efficacy
Active immunization (hepatitis B)
Interaction
Structure map
map07044  Antiviral agents
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07B VIRAL VACCINES
    J07BC Hepatitis vaccines
     J07BC01 Hepatitis B, purified antigen
      D06475  Adsorbed hepatitis B vaccine (JP18) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   631  Vaccines
    6313  Viral vaccines
     D06475  Adsorbed hepatitis B vaccine (JP18)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D06475  Adsorbed hepatitis B vaccine
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D06475
Other DBs
PubChem: 47208131
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system